Optimizing Antiplatelet Therapy in Chronic Kidney Disease: Insights From the TICO Trial in the Context of Contemporary Guidelines.

Korean Circ J · 2025 · PMC12505330 · PMID 40736386

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Although the reduction in MACCE did not reach statistical significance in either group, event rates were numerically lower with monotherapy, and no signal of increased ischemic events was observed.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.